728
Views
15
CrossRef citations to date
0
Altmetric
Review

Prophylaxis for hemophilia A without inhibitors: treatment options and considerations

&
Pages 731-743 | Received 09 Mar 2020, Accepted 26 May 2020, Published online: 23 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

E. Carlos Rodriguez-Merchan. (2023) Total elbow arthroplasty in hemophilia: a high-risk surgical procedure. Expert Review of Hematology 0:0, pages 1-3.
Read now
E. Carlos Rodriguez-Merchan. (2023) Synovitis in hemophilia: preventing, detecting, and treating joint bleeds. Expert Review of Hematology 16:7, pages 525-534.
Read now
Nuria Blazquez-Ramos, José A. Romero-Garrido, Luis Gonzalez Del Valle, Victoria L. Collada-Sanchez, María Teresa Alvarez-Roman, Victor Jimenez-Yuste, Monica Martin-Salces, Hortensia De la Corte-Rodriguez, Alicia Herrero-Ambrosio, Juana Benedi-Gonzalez & E. Carlos Rodriguez-Merchan. (2023) Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies. Expert Review of Hematology 16:3, pages 213-226.
Read now
Steven W. Pipe, Gil Gonen-Yaacovi & Oscar G. Segurado. (2022) Hemophilia A gene therapy: current and next-generation approaches. Expert Opinion on Biological Therapy 22:9, pages 1099-1115.
Read now
E. Carlos Rodriguez-Merchan, Hortensia De la Corte-Rodriguez, Teresa Alvarez-Roman, Primitivo Gomez-Cardero, Carlos A. Encinas-Ullan & Victor Jimenez-Yuste. (2022) Total knee arthroplasty in hemophilia: lessons learned and projections of what’s next for hemophilic knee joint health. Expert Review of Hematology 15:1, pages 65-82.
Read now
Emanuela Marchesini, Massimo Morfini & Leonard Valentino. (2021) Recent Advances in the Treatment of Hemophilia: A Review. Biologics: Targets and Therapy 15, pages 221-235.
Read now

Articles from other publishers (8)

Sokhna Aïssatou Touré, Moussa Seck, Diariatou Sy, Alioune Badara Senghor, Blaise Felix Faye & Saliou Diop. (2023) Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa. Hematology, Transfusion and Cell Therapy 45, pages S95-S100.
Crossref
Romeo Gabriel Mihaila. (2023) From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A. Biomedical Papers 167:1, pages 1-8.
Crossref
Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Ronald J Bernardi, Víctor Jiménez-Yuste, Benjamin M Beckermann, Christophe Schmitt, Giuliana Ventriglia, Jerzy Windyga, Roseline d'Oiron, Paul Moorehead, Sunita Koparkar, Vanda Teodoro, Amy D Shapiro, Johannes Oldenburg & Cedric Hermans. (2023) Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. The Lancet Haematology 10:3, pages e168-e177.
Crossref
Marie Cadé, Javier Muñoz-Garcia, Antoine Babuty, Marc Fouassier, Marie-Francoise Heymann, Paul E. Monahan & Dominique Heymann. (2022) FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis. Drug Discovery Today 27:1, pages 102-116.
Crossref
E. Carlos Rodriguez-Merchan. (2021) Management of Musculoskeletal Complications in Patients with Hemophilia: Literature Review and Expert Recommendations. Cardiovascular & Hematological Disorders-Drug Targets 21:3, pages 162-166.
Crossref
Roberta Gualtierotti, Luigi Piero Solimeno & Flora Peyvandi. (2021) Hemophilic arthropathy: Current knowledge and future perspectives. Journal of Thrombosis and Haemostasis 19:9, pages 2112-2121.
Crossref
Leszek Lisowski, Janice M. Staber, J. Fraser Wright & Leonard A. Valentino. (2021) The intersection of vector biology, gene therapy, and hemophilia. Research and Practice in Thrombosis and Haemostasis 5:6, pages e12586.
Crossref
Maria Sol Cruz, Josefina Santillan, Julieta Lesser, Juan Pablo Ortiz & Laura Forzani. (2021) Personalised Prophylaxis in a Child with Haemophilia A and Type 1 Diabetes. Clinics and Practice 11:2, pages 287-292.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.